Inogen (INGN)


Financial Snapshot (Last 12 Months):

Market Cap: $306.80M Revenues: $69.50M Net Income: $-3.50M

Deal Structure

Filing Date:Nov. 29, 2013 Expected to Trade:Feb. 14, 2014 Status:Priced Lead Underwriters:J.P. Morgan Co-Managers:Leerink Swann; Blair; Stifel
Shares Offered:4.41M Deal Type:IPO Price Range:$16.00 - $18.00 Issue Price:$16.00

Company

Business Profile

We are a medical technology company that develops, manufactures and markets innovative portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Traditionally, these patients have relied on stationary oxygen concentrator systems for use in the home and oxygen tanks or cylinders for mobile use, which we call the delivery model. The tanks and cylinders must be delivered regularly and have a finite amount of oxygen, which requires patients to plan activities outside of their homes around delivery schedules and a finite oxygen supply.

Industry: Health Care Founded: 2001 Employees: 354 Prospectus: Click Here

comments powered by Disqus